Elisabet Ametller

1.6k total citations
26 papers, 943 citations indexed

About

Elisabet Ametller is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Elisabet Ametller has authored 26 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Oncology. Recurrent topics in Elisabet Ametller's work include Adipose Tissue and Metabolism (9 papers), Muscle Physiology and Disorders (7 papers) and Muscle metabolism and nutrition (4 papers). Elisabet Ametller is often cited by papers focused on Adipose Tissue and Metabolism (9 papers), Muscle Physiology and Disorders (7 papers) and Muscle metabolism and nutrition (4 papers). Elisabet Ametller collaborates with scholars based in Spain, United States and Italy. Elisabet Ametller's co-authors include Vanessa Almendro, Francisco J. López‐Soriano, Josep M. Argilés, Sı́lvia Busquets, Gemma Fuster, Pedro Gascón, Mario Mancino, Maite Figueras, Susana García‐Recio and Rodrigo Moore‐Carrasco and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Elisabet Ametller

25 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabet Ametller Spain 17 489 342 183 176 170 26 943
Shephali Bhatnagar United States 19 1.2k 2.5× 525 1.5× 66 0.4× 53 0.3× 123 0.7× 23 1.7k
Roberta Buono Italy 12 523 1.1× 513 1.5× 87 0.5× 29 0.2× 43 0.3× 33 1.2k
David Bargiela United Kingdom 17 412 0.8× 94 0.3× 180 1.0× 42 0.2× 150 0.9× 30 855
Elisa Dominguez France 13 531 1.1× 284 0.8× 77 0.4× 34 0.2× 187 1.1× 14 1.4k
Duccio Rossi Degl’Innocenti Italy 16 214 0.4× 145 0.4× 113 0.6× 50 0.3× 89 0.5× 36 721
Masaki Tanaka Japan 11 377 0.8× 173 0.5× 70 0.4× 71 0.4× 165 1.0× 24 697
Sherry L. Abboud‐Werner United States 13 353 0.7× 392 1.1× 168 0.9× 36 0.2× 183 1.1× 16 1.0k
Ann‐Cathrine Jönsson‐Rylander Sweden 14 357 0.7× 74 0.2× 60 0.3× 39 0.2× 176 1.0× 26 911
Timur Naim Australia 17 759 1.6× 453 1.3× 45 0.2× 34 0.2× 68 0.4× 36 960
Masahide Fujita Japan 18 347 0.7× 272 0.8× 222 1.2× 45 0.3× 101 0.6× 63 949

Countries citing papers authored by Elisabet Ametller

Since Specialization
Citations

This map shows the geographic impact of Elisabet Ametller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabet Ametller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabet Ametller more than expected).

Fields of papers citing papers by Elisabet Ametller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabet Ametller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabet Ametller. The network helps show where Elisabet Ametller may publish in the future.

Co-authorship network of co-authors of Elisabet Ametller

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabet Ametller. A scholar is included among the top collaborators of Elisabet Ametller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabet Ametller. Elisabet Ametller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ametller, Elisabet, et al.. (2015). Comparison of methods for the isolation of human breast epithelial and myoepithelial cells. Frontiers in Cell and Developmental Biology. 3. 32–32. 23 indexed citations
2.
Carbó, Neus, Carmen Rodrı́guez, Gemma Fuster, et al.. (2014). 550: A functional Cav1-Fas interplay as a new mechanism of chemoresistance in colon cancer. European Journal of Cancer. 50. S133–S133. 1 indexed citations
3.
García‐Recio, Susana, Gemma Fuster, Patricia Fernández‐Nogueira, et al.. (2013). Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer. Cancer Research. 73(21). 6424–6434. 76 indexed citations
4.
Ametller, Elisabet, Susana García‐Recio, Gerard Callejo, et al.. (2011). Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death. Cancer Biology & Therapy. 11(1). 4–13. 9 indexed citations
5.
Mayordomo, Cristina, Susana García‐Recio, Elisabet Ametller, et al.. (2011). Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2. Journal of Cellular Physiology. 227(4). 1358–1366. 69 indexed citations
6.
Ametller, Elisabet, Sı́lvia Busquets, Gemma Fuster, et al.. (2011). Effects of formoterol on protein metabolism in myotubes during hyperthermia. Muscle & Nerve. 43(2). 268–273. 5 indexed citations
7.
Mancino, Mario, Elisabet Ametller, Pedro Gascón, & Vanessa Almendro. (2011). The neuronal influence on tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1816(2). 105–118. 126 indexed citations
8.
Argilés, Josep M., Cibely Cristine Fontes de Oliveira, Gemma Fuster, et al.. (2010). Patterns of gene expression in muscle and fat in tumor‐bearing rats: Effects of CRF2R agonist on cachexia. Muscle & Nerve. 42(6). 936–949. 4 indexed citations
9.
Ametller, Elisabet, Susana García‐Recio, Domiziana Costamagna, et al.. (2010). Tumor promoting effects of CD95 signaling in chemoresistant cells. Molecular Cancer. 9(1). 161–161. 18 indexed citations
10.
Almendro, Vanessa, Elisabet Ametller, Susana García‐Recio, et al.. (2009). The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin. PLoS ONE. 4(3). e4728–e4728. 67 indexed citations
11.
Vargas, Mara Ambrosina de Oliveira, Izaskun Valduvieco, Vanessa Almendro, et al.. (2008). Radiosensitivity enhancement by dual HER-1/2 inhibitor (GW572016) in SKBR3 human breast carcinoma HER-2+ cell line. Journal of Clinical Oncology. 26(15_suppl). 22112–22112.
12.
Moore‐Carrasco, Rodrigo, Maite Figueras, Elisabet Ametller, et al.. (2008). Effects of the PPARγ agonist GW1929 on muscle wasting in tumour-bearing mice. Oncology Reports. 19(1). 253–6. 11 indexed citations
13.
Barreiro, Esther, Cèlia Garcı́a-Martı́nez, Elisabet Ametller, et al.. (2008). UCP3 overexpression neutralizes oxidative stress rather than nitrosative stress in mouse myotubes. FEBS Letters. 583(2). 350–356. 33 indexed citations
14.
Almendro, Vanessa, Gemma Fuster, Sı́lvia Busquets, et al.. (2008). Effects of IL‐15 on Rat Brown Adipose Tissue: Uncoupling Proteins and PPARs. Obesity. 16(2). 285–289. 43 indexed citations
15.
Busquets, Sı́lvia, Gemma Fuster, Elisabet Ametller, et al.. (2007). Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Clinical Nutrition. 26(2). 239–244. 41 indexed citations
16.
Argilés, Josep M., Maite Figueras, Elisabet Ametller, et al.. (2007). Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells. Muscle & Nerve. 37(2). 190–195. 18 indexed citations
17.
Busquets, Sı́lvia, Elisabet Ametller, Gemma Fuster, et al.. (2006). Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Letters. 245(1-2). 144–148. 69 indexed citations
18.
Almendro, Vanessa, Sı́lvia Busquets, Elisabet Ametller, et al.. (2006). Effects of interleukin-15 on lipid oxidation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761(1). 37–42. 46 indexed citations
19.
Moore‐Carrasco, Rodrigo, Cèlia Garcı́a-Martı́nez, Sı́lvia Busquets, et al.. (2006). The AP‐1/CJUN signaling cascade is involved in muscle differentiation: Implications in muscle wasting during cancer cachexia. FEBS Letters. 580(2). 691–696. 27 indexed citations
20.
Busquets, Sı́lvia, Gemma Fuster, Vanessa Almendro, et al.. (2004). Anticachectic Effects of Formoterol. Cancer Research. 64(18). 6725–6731. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026